Athira Pharma, Inc.·4

Apr 16, 4:37 PM ET

San Martin Javier 4

4 · Athira Pharma, Inc. · Filed Apr 16, 2024

Insider Transaction Report

Form 4
Period: 2024-04-15
San Martin Javier
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-04-15+400,000400,000 total
    Exercise: $2.06Exp: 2034-04-14Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option will vest on the one (1) year anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2024 Inducement Equity Incentive Plan) through the applicable vesting dates.

Documents

1 file
  • 4
    form4-04162024_080456.xmlPrimary